New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alector, Inc.
ALEC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

134M

Biotechnology

Next Earning date - 14 May 2025

134M

Biotechnology

Next Earning date - 14 May 2025

1.35USD

Shape0.05 ( 3.85%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

18%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

80%

Quote Panel

Shape
Updated March 23, 2025
1W -2.17 % 1M -24.16 % 3M -27.03 % 1Y -77.39 %

Key Metrics

Shape
  • Market Cap

    133.77M


  • Shares Outstanding

    99.09M


  • Share in Float

    74.94M


  • Dividende

    0


  • Earning Date

    14 May 2025


  • Price Target

    1.35


  • Average Volume

    763276


  • Beta

    0.648


  • Range

    1.26-6.78


  • Industry

    Biotechnology


  • Website

    https://www.alector.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.33x

P/S Ratio

1.03x

P/B Ratio

0.3

Debt/Equity

-118.4%

Net Margin

$-1.2

EPS

How ALEC compares to sector?

P/E Ratio

Relative Strength

Shape

ALEC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$27M

Shape-51%

2025-Revenue

$1.81

Shape-8308%

2025-EPS

$22M

Shape-323%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Keefe, Bruyette & Woods

upgrade

Previous: Not converted

2023-12-14

Now: Buy

Morgan Stanley

downgrade

Previous: Not converted

2022-09-09

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.55
vs -0.54

Q2.23

arrow
arrow

-83%

0.02
vs 0.12

Q3.23

arrow
arrow

N/A

-0.53
vs -0.56

Q4.23

arrow
arrow

N/A

-0.49
vs -0.63

Q1.24

arrow
arrow

N/A

-0.38
vs -0.55

Q2.24

arrow
arrow

N/A

-0.40
vs 0.02

Q3.24

arrow
arrow

N/A

-0.43
vs -0.53

Q4.24

arrow
arrow

N/A

-0.02
vs -0.49

Q1.25

arrow
arrow

N/A

-0.48
vs -0.38

Q2.25

arrow
arrow

N/A

-0.50
vs -0.40

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-32%

16.5M  vs 24.5M

Q2.23

arrow
arrow

-30%

56.2M  vs 79.9M

Q3.23

arrow
arrow

-39%

9.1M  vs 14.9M

Q4.23

arrow
arrow

+5%

15.2M  vs 14.4M

Q1.24

arrow
arrow

-4%

15.9M  vs 16.5M

Q2.24

arrow
arrow

-73%

15.1M  vs 56.2M

Q3.24

arrow
arrow

+68%

15.3M  vs 9.1M

Q4.24

arrow
arrow

+257%

54.2M  vs 15.2M

Q1.25

arrow
arrow

-72%

4.4M  vs 15.9M

Q2.25

arrow
arrow

-71%

4.4M  vs 15.1M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-25%

-0.25
vs -0.24

Q2.23

arrow
arrow

+1%

0.01
vs -0.25

Q3.23

arrow
arrow

-27%

-0.27
vs 0.01

Q4.23

arrow
arrow

-31%

-0.31
vs -0.27

Q1.24

arrow
arrow

-20%

-0.20
vs -0.31

Q2.24

arrow
arrow

-26%

-0.26
vs -0.20

Q3.24

arrow
arrow

-35%

-0.35
vs -0.26

Q4.24

arrow
arrow

-2%

-0.02
vs -0.35

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

150

150
vs 158

-5%

Q2.23

arrow
arrow

145

145
vs 150

-3%

Q3.23

arrow
arrow

150

150
vs 145

3%

Q4.23

arrow
arrow

151

151
vs 150

1%

Q1.24

arrow
arrow

160

160
vs 151

6%

Q2.24

arrow
arrow

163

163
vs 160

2%

Q3.24

arrow
arrow

164

164
vs 163

1%

Q4.24

arrow
arrow

152

152
vs 164

-7%

Earnings Growth

Latest News